Evidence map›Paper›PMID 24490053›Full record

ArticleJournal of transplantation2013

The natural history of biopsy-negative rejection after heart transplantation.

Zhaoyi Tang, Jon Kobashigawa, Matthew Rafiei, Lily Kagan Stern, Michele Hamilton

Open access · goldAbstract read
In one paragraph

Article in Journal of transplantation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. JHLT open · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. The evolving use of biomarkers in heart transplantation: Consensus of an expert panel.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2023
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zhaoyi TangCedars-Sinai Heart Institute, 127 South San Vicente Boulevard, Third Floor Cardiology, A3107, Los Angeles, CA 90048, USA.
Jon KobashigawaCedars-Sinai Heart Institute, 127 South San Vicente Boulevard, Third Floor Cardiology, A3107, Los Angeles, CA 90048, USA.
Matthew RafieiCedars-Sinai Heart Institute, 127 South San Vicente Boulevard, Third Floor Cardiology, A3107, Los Angeles, CA 90048, USA.
Lily Kagan SternCedars-Sinai Heart Institute, 127 South San Vicente Boulevard, Third Floor Cardiology, A3107, Los Angeles, CA 90048, USA.
Michele HamiltonCedars-Sinai Heart Institute, 127 South San Vicente Boulevard, Third Floor Cardiology, A3107, Los Angeles, CA 90048, USA.
Cedars-Sinai Smidt Heart Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose. The most recent International Society for Heart and Lung Transplantation (ISHLT) biopsy scale classifies cellular and antibody-mediated rejections. However, there are cases with acute decline in left ventricular ejection fraction (LVEF ≤ 45%) but no evidence of rejection on biopsy. Characteristics and treatment response of this biopsy negative rejection (BNR) have yet to be elucidated. Methods. Between 2002 and 2012, we found 12 cases of BNR in 11 heart transplant patients as previously defined. One of the 11 patients was treated a second time for BNR. Characteristics and response to treatment were noted. Results. 12 cases (of 11 patients) were reviewed and 11 occurred during the first year after transplant. 8 cases without heart failure symptoms were treated with an oral corticosteroids bolus and taper or intravenous immunoglobulin. Four cases with heart failure symptoms were treated with thymoglobulin, intravenous immunoglobulin, and intravenous methylprednisolone followed by an oral corticosteroids bolus and taper. Overall, 7 cases resulted in return to normal left ventricular function within a mean of 14 ± 10 days from the initial biopsy. Conclusion. BNR includes cardiac dysfunction and can be a severe form of rejection. Characteristics of these cases of rejection are described with most cases responding to appropriate therapy.

Identifiers

PMID24490053
PMCPMC3893856
OpenAlexW2054977011

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.